Journey Advisory Group LLC boosted its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 19.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 12,908 shares of the financial services provider's stock after buying an additional 2,104 shares during the quarter. Journey Advisory Group LLC's holdings in CME Group were worth $3,558,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Heartland Bank & Trust Co acquired a new position in CME Group in the 1st quarter worth approximately $377,000. Catalyst Capital Advisors LLC boosted its stake in CME Group by 256.9% in the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock worth $971,000 after purchasing an additional 2,636 shares during the period. OMNI 360 Wealth Inc. acquired a new position in CME Group in the 1st quarter worth approximately $367,000. Fulcrum Equity Management acquired a new position in CME Group in the 1st quarter worth approximately $258,000. Finally, AIA Group Ltd boosted its stake in CME Group by 17.8% in the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock worth $4,416,000 after purchasing an additional 2,510 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms recently commented on CME. Oppenheimer raised their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Piper Sandler raised their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 15th. TD Cowen raised their price objective on shares of CME Group from $281.00 to $288.00 and gave the stock a "hold" rating in a research note on Wednesday, October 8th. Finally, Weiss Ratings reissued a "buy (b)" rating on shares of CME Group in a research note on Wednesday, October 8th. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $283.71.
View Our Latest Stock Report on CME
CME Group Trading Up 2.1%
Shares of NASDAQ:CME opened at $267.93 on Monday. The firm has a fifty day moving average of $267.30 and a two-hundred day moving average of $271.40. The firm has a market capitalization of $96.56 billion, a P/E ratio of 25.94, a price-to-earnings-growth ratio of 6.16 and a beta of 0.41. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.
CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the business posted $2.56 EPS. On average, equities analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were issued a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's dividend payout ratio (DPR) is currently 48.40%.
Insider Buying and Selling at CME Group
In other news, insider Timothy Francis Mccourt sold 379 shares of the firm's stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm's stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the transaction, the general counsel owned 7,851 shares in the company, valued at $2,056,962. This represents a 4.76% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock worth $3,527,956 over the last quarter. Company insiders own 0.30% of the company's stock.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.